Mira Pharmaceuticals
(NASDAQ) MIRA
Mira Pharmaceuticals Financials at a Glance
Market Cap
$44.54M
Revenue (TTM)
$0.00
Net Income (TTM)
$32.00M
EPS (TTM)
$-1.52
P/E Ratio
-0.70
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.07
Volume
3,414
Open
$1.07
Price
$1.07
Volume
3,414
Open
$1.07
Previous Close
$1.07
Daily Range
$1.07 - $1.09
52-Week Range
$0.84 - $2.45
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.07
Volume
3,414
Open
$1.07
Previous Close
$1.07
Daily Range
$1.07 - $1.09
52-Week Range
$0.84 - $2.45
MIRA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mira Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
2
CEO
Erez Aminov
Website
mirapharmaceuticals.comHeadquarters
Baltimore, MD 21205, US
MIRA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-508%
Return on Capital
-1%
Return on Assets
-3%
Earnings Yield
-1.43%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$44.54M
Shares Outstanding
42.02M
Volume
3.41K
Short Interest
0.00%
Avg. Volume
160.47K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$10.49M
EBITDA
$10.49M
Operating Cash Flow
$4.66M
Capital Expenditure
$0.00
Free Cash Flow
$4.66M
Cash & ST Invst.
$6.35M
Total Debt
$0.00
Mira Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$44.54M
N/A
Market Cap/Employee
$22.27M
N/A
Employees
2
N/A
Net Income
$5.98M
-149.3%
EBITDA
$5.82M
-138.9%
Quarterly Fundamentals
Net Cash
$6.35M
+124.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-2.88%
N/A
Return on Invested Capital
-1.01%
N/A
Free Cash Flow
$1.14M
+37.1%
Operating Cash Flow
$1.14M
+37.1%